2019
DOI: 10.1111/ner.12971
|View full text |Cite
|
Sign up to set email alerts
|

Response to “Safety Analysis of Dorsal Root Ganglion Stimulation in the Treatment of Chronic Pain”

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 4 publications
0
1
0
Order By: Relevance
“…Recent conflicting reports have retrospectively queried databases (using a directly supplied, manufacturer database (26), or the FDA's Manufacturer and User Facility Device Experience (25)) to evaluate the safety of DRG stimulation. Their estimates of adverse event are discrepant, particularly on lead migration and lead fracture (31,32), which were major contributors to complications in our cohort. The prospectively collected complications‐data in our cohort contribute to this debate of long‐term safety of DRG stimulation (in addition to its long‐term efficacy).…”
Section: Discussionmentioning
confidence: 72%
“…Recent conflicting reports have retrospectively queried databases (using a directly supplied, manufacturer database (26), or the FDA's Manufacturer and User Facility Device Experience (25)) to evaluate the safety of DRG stimulation. Their estimates of adverse event are discrepant, particularly on lead migration and lead fracture (31,32), which were major contributors to complications in our cohort. The prospectively collected complications‐data in our cohort contribute to this debate of long‐term safety of DRG stimulation (in addition to its long‐term efficacy).…”
Section: Discussionmentioning
confidence: 72%